Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
A new drug dubbed the “King Kong” of weight-loss jabs will be available in Ireland early next year, it was confirmed ...
The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that ...
Given the scale of the NHS's problems, from waiting times at record levels to overloaded A&E units, you might have thought it ...
The NHS is always keen to tell us that obesity dents its finances, yet it's just ensured that this sorry state of affairs ...
Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.
The expansion of a newly acquired facility in Wisconsin is Lilly’s largest U.S. manufacturing investment outside of Indiana ...
The NHS is about to start doling out ‘the King Kong of weight loss drugs’ to obese patients – the scandal, needless to say, ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Lilly's Zepbound superior to Wegovy in head-to-head trial showing an average weight loss of 20.2% vs. 13.7% ...
A study published in Nature estimates the economic burden associated with obesity on major US industries to be in excess of $347bn in 2023.
Eli Lilly and Company announced a significant expansion at its Pleasant Prairie facility Thursday. The pharmaceutical giant plans a $3 billion investment, which is expected to create 750 new jobs at ...